Acrônimos - O

OASIS - 2
Organisation to Assess Strategies for Ischemic Syndromes-2
OPTIMAAL
OPtimal Trial In Myocardial infarction with Angiotensin II Antagonist Losartan
OPUS TIMI 16
A phase III international randomized, double-blind placebo-controlled trial evaluating the efficacy and safety of Orbofiban in Patients with Unstable Coronary Syndromes. The OPUS TIMI 16 trial
ORBIT
Oral glycoprotein IIb/IIIa Receptor Blockade to Inhibit Thrombosis
OSIRIS
Optimization Study of Infarct Reperfusion Investigated by ST-monitoring

Apoio: Farmacêutica